HRT Financial’s Ocular Therapeutix OCUL Stock Holding History

HRT Financial’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.01M	Buy	709,218 +306,255	+76%	+$2.92M	0.02%	893
2025 Q4	$4.89M	Buy	402,963 +80,049	+25%	+$972K	0.02%	797
2025 Q3	$3.77M	Buy	+322,914	New	+$3.86M	0.02%	810
2023 Q3	–	Sell	-54,360	Closed	-$280K	–	2911
2023 Q2	$280K	Buy	+54,360	New	+$323K	﹤0.01%	1666
2022 Q4	–	Sell	-10,868	Closed	-$45K	–	2973
2022 Q3	$45K	Buy	+10,868	New	+$54.7K	﹤0.01%	2451
2022 Q2	–	Sell	-10,370	Closed	-$51K	–	3527
2022 Q1	$51K	Buy	+10,370	New	+$57.5K	﹤0.01%	2744
2021 Q4	–	Sell	-71,736	Closed	-$717K	–	3844
2021 Q3	$717K	Buy	71,736 +31,331	+78%	+$352K	﹤0.01%	1696
2021 Q2	$572K	Buy	+40,405	New	+$614K	0.01%	1636
2020 Q4	–	Sell	-11,165	Closed	-$84K	–	2299
2020 Q3	$84K	Buy	+11,165	New	+$92.7K	﹤0.01%	1573
2020 Q1	–	Sell	-19,800	Closed	-$78K	–	1214
2019 Q4	$78K	Buy	+19,800	New	+$68.8K	﹤0.01%	1045

Other funds holding OCUL

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return